Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.

MLA

Wachman, Elisha M., et al. “Impact of Psychiatric Medication Co-Exposure on Neonatal Abstinence Syndrome Severity.” Drug & Alcohol Dependence, vol. 190, Sept. 2018, pp. 45–50. EBSCOhost, https://doi.org/10.1016/j.drugalcdep.2018.07.024.

APA

Wachman, E. M., Warden, A. H., Thomas, Z., Thomas-Lewis, J. A., Shrestha, H., Nikita, F. N. U., Shaw, D., Saia, K., Schiff, D. M., & Warden, A. H. (2018). Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. Drug & Alcohol Dependence, 190, 45–50. https://doi.org/10.1016/j.drugalcdep.2018.07.024

Chicago

Wachman, Elisha M, A Hutchinson Warden, Zoe Thomas, Jo Ann Thomas-Lewis, Hira Shrestha, F N U Nikita, Daniel Shaw, Kelley Saia, Davida M Schiff, and A Hutcheson Warden. 2018. “Impact of Psychiatric Medication Co-Exposure on Neonatal Abstinence Syndrome Severity.” Drug & Alcohol Dependence 190 (September): 45–50. doi:10.1016/j.drugalcdep.2018.07.024.